Reckitt to Start Strategic Review of Pharmaceutical Unit

22-10-2013 BloombergComments (0)

PharmaceuticalReckitt Benckiser

Reckitt Benckiser Group Plc, (RB/) the maker of Nurofen painkillers and Durex condoms, said it will start a strategic review of its pharmaceutical unit following calls from analysts for it to exit the business. The review will take “some time” and ...

Read more on Bloomberg

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top